World Hepatitis Day 2018
On the occasion of World Hepatitis Day, ECDC launched online prevalence database for hepatitis B and C which included data mainly based on peer-reviewed cross sectional studies from 2006 onwards.
Systematic review on the prevention and control of blood-borne viruses in prison settings
The objective of this report was to systematically review data on prevention and control of BBVs in prison settings, with a focus on the countries of the European Union (EU) and the European Economic Area (EEA).
Guidance in brief: Prevention and control of blood-borne viruses in prison settings
This guidance is intended for policymakers responsible for the planning and delivery of healthcare services in the national or sub-national custodial system and all professionals responsible for the health and well-being of people in prison, including community-based service providers and those facilitating continuity of care in the community.
Preventing blood-borne viruses in prison settings: ECDC and EMCDDA Guidance
In their joint public health guidance published today at AIDS 2018, ECDC and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) outline evidence-based and effective measures to help prevent and control the transmission of blood-borne viruses in prison settings.
Public health guidance on prevention and control of blood-borne viruses in prison settings
This document provides EU/EEA Member States with evidence-based scientific advice on available options, when planning and implementing prevention and control interventions for blood-borne viruses in prison settings.
Hepatitis B - Annual Epidemiological Report for 2016
In 2016, 30 EU/EEA Member States reported 29 307 cases of hepatitis B virus (HBV) infection, corresponding to a crude rate of 5.5 cases per 100 000 population.
Hepatitis C - Annual Epidemiological Report for 2016
In 2016, 33 860 cases of hepatitis C were reported in 29 EU/EEA Member States, corresponding to a crude rate of 7.4 cases per 100 000 population.
Laboratory testing of non-partner sperm donors
The European Centre for Disease Prevention and Control was asked by the European Commission to assess the risk involved in changing the testing requirements for HIV (human immunodeficiency virus), hepatitis B virus (HBV), and hepatitis C virus (HCV) with regard to the quality and safety of non-partner semen donations.
Hepatitis A - Annual Epidemiological Report for 2015
In 2015, 29 EU/EEA countries reported a total of 12 641 cases of hepatitis A, 12 527 (99.1%) of which were confirmed.